Navigation Links
NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance
Date:2/13/2008

full year (excluding the effects of non-cash IBNR malpractice reserves,

stock compensation, and a one-time charge related to the settlement of

an acquisition-related legal dispute) while investing in both

infrastructure and new services. As previously reported, the company

also incurred higher short-term expense in 2007 related to the

integration of various acquisitions.

"We accomplished a great deal in 2007," said Dr. Paul Berger, Chairman and Chief Executive Officer. "Our continued growth and profitability in this highly dynamic industry demonstrates the value and quality of our services and the success of our business model. Customers rely on NightHawk to meet their current and future needs with our advanced and innovative solutions, and our affiliated radiologists are some of the most productive in the world. We have made important investments in 2007 in new services, acquisitions and infrastructure. These items, combined with strong industry fundamentals, will enable NightHawk to continue growing rapidly while leading the transformation of the practice of radiology."

Full-Year Results

-- Full-year revenue grew 65% to $151.7 million from $92.2 million for the

full-year 2006. Full-year scan volumes grew 62% to 2.7 million, scans

compared with 1.7 million scans in 2006.

-- Organic revenue and organic scan volumes grew 23% and 27%,

respectively, year-over-year.

-- New service offerings, including daytime final and subspecialty reads,

cardiac 3D reconstructions and interpretations, and business services,

represented 15% of total revenue for the year. Final interpretations

comprised approximately 8% of revenue.

-- Adjusted net income grew 35% to $28.3 million, or $0.91 per diluted

share, from $20.9 million, or $0.70 per diluted share in the prior

year. The company's adjusted net income excludes cert
'/>"/>

SOURCE NightHawk Radiology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call
2. NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results
3. NightHawk Radiology Holdings, Inc. to Speak at Annual Piper Jaffray Healthcare Conference on November 28, 2007
4. NightHawk Radiology: One Source, One Solution
5. NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008
6. NightHawk Radiology Holdings, Inc. Announces Preliminary 2007 Results
7. NightHawk Radiology Holdings, Inc. Announces Date for Fourth Quarter and Full-Year 2007 Earnings Conference Call
8. NightHawk Radiology exclusive radiology provider for high-risk plaque research initiative
9. NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call
10. AIUM CEO named among most influential in radiology
11. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Two expert therapists offer advice on the topic ...: verb: to leave completely and finally; forsake ...couver, Canada (Vocus) November 24, 2009 -- Dr. Su... the second webinar is its groundbreaking "Th...es from MyShrink.com ( http://www.myshrink.com ).,...
(Date:11/24/2009)... NCL Security Launches EyeCentral Remote Video Pl...ring Monthly Revenue for Central Stations and Secu...exas (PRWEB) November 24, 2009 -- NCL Security Lau...urity Industry to Generate Recurring Monthly Reven..."Integrated security systems has been and sti...
(Date:11/23/2009)...niversity of Michigan determined that only 663,000...epatitis C virus (HCV) infection received antivira...appear to be declining, in part because only half ...isturbing trend continues, by 2030 less than 15% o...by antiviral therapy. This study, the first to an...
(Date:11/23/2009)... the hook for the high cost of drug advertising th...study led by a University of British Columbia heal...day in the Archives of Internal Medicine , examin...ling drug also known by the trade name Plavix used...ke. The drug was selected to study the impact of a...
(Date:11/23/2009)...eraction might ease the problem, researchers say ,...en who bottle up their anger over unfair treatment...ish study indicates. , Men who consistently fai...h a fellow worker or supervisor were more than twi...t disease as those who vented their anger, claims ...
Breaking Medicine News(10 mins):Health News:Home For the Holidays: MyShrink.com Announces the Second in its Successful Six-Part Webinar Series: "Abandonment: The Hidden Fear" 2Health News:NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Dealers 2Health News:Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US 2Health News:Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3
...District,Court for the District of Massachusetts h...ttlements on behalf of a class of people and entit...intiffs filed the lawsuits, New,England Carpenters...how the published price of drugs are,determined, w...
...Oncology (ESMO), together with Oxford Journals, an...are pleased to announce a new collaboration which ...cology becoming the official scientific publicatio...by JSMO and all members of the Japanese society wi...
...007 Naltrexone is one of four oral medications ap...DA) for the treatment of alcoholism. A recent lar...e supported by the National Institute of Alcoholis...n, acamprosate, was ineffective. Perhaps consiste...
... 19, 2007 -- New research, including two studies p...he European Association for the Study of Diabetes ...of ACTOS (pioglitazone HCI) and its benefits reg... reinforce the consistency of pioglitazone data an...
...idwest,Dairy Association has introduced a new Grid...retail grocery stores for the 2007 NFL season. Oma... is distributing the product,line in Kansas, Misso...hts NFLRush.com, the NFL,s interactive website for...
...ission Limits, Buffer Zones to Protect ...ept. 18 The Fresno County Board of,Supervisors de...osal for,improving the Central Valley,s air qualit...w. The Fresno Healthy Dairy Commission had sought...
Other Medicine News:Health News:Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals 2Health News:Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals 3Health News:ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration 2Health News:Family history of alcoholism affects response to drug used to treat heavy drinking 2Health News:New research shows ACTOS is associated with a 38 percent lower risk of heart attack 2Health News:NFL-Themed Milk Touches Down in Schools and Retail Grocery Stores 2Health News:NFL-Themed Milk Touches Down in Schools and Retail Grocery Stores 3Health News:County Board Punts to Planning Commission On Clean-Air Issue 2
(Date:11/23/2009)...valsoftwonewtherapiesforNon-Hodgkin,sLymphomas(NHL...fatumumab(Azerra(TM),GlaxoSmithKline)asatherapyopt...ndromidepsin(Istodax(R),GloucesterPharmaceuticals)...llymphoma(CTCL). ,, FORTWASHINGTON,Pa.,Nov.23/P...omptedtheNationalComprehensiveCancerNetwork( NCCN ...
(Date:11/23/2009)...swire/--Reportlinker.comannouncesthatanewmarketres...hesiaDisposables-AWorldMarketReview ,, http:...bles---A-World-Market-Review.html#utm_source=prnew...e ,, Globalgeneralanesthesiadisposablesmark...theconsiderablerisewitnessedingeneralsurgicalproce...
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/-- LexiconPharmaceutica...datafromitsPhase2clinicalstudywith LX1031 inpatien...illbepresentedatGASTRO2009inLondonthisweek.Results...BSsymptoms,willbepresentedbyDr. PhilipM.Brown ,Lex...ovember25,2009at2:30pmlocaltimeatthesessionentitle...
Breaking Medicine Technology:NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3MSU scientists 3A Progesterone leads to inflammation 54891 1MSU scientists 3A Progesterone leads to inflammation 54891 2Vanderbilt joins national consortium to develop new cancer therapies 54888 1Vanderbilt joins national consortium to develop new cancer therapies 54888 2Vanderbilt joins national consortium to develop new cancer therapies 54888 3American Society for Microbiology honors Tobias M Hohl for work on Aspergillus fumigatus 9622 1American Society for Microbiology honors Tobias M Hohl for work on Aspergillus fumigatus 9622 2American Society for Microbiology honors Tobias M Hohl for work on Aspergillus fumigatus 9622 3
...il 30 Arrayit Corporation (OTC Bulletin Board: AR...es for disease prevention, treatment and cure, ann...sed diagnostic test to detect the H1N1 swine flu v...s and clinicians to detect the presence of the vir...nguish the threatening mutated strain from less ha...
...in the second half of this year , , BERLIN and TA...egeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) t...eir global development program for VEGF Trap-Eye, ...ain eye diseases, to include Central Retinal Vein ... Phase 3 program evaluating the efficacy and safet...
Other Medicine Technology:Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip 2Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip 3Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion 2Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion 3Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion 4Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion 5
Brooks Brothers Ophthalmic Collection
Chanel Optical Collection
...lly fresh restatement of everything thats creative...gamo.,The creations include eighteen ladies models...odels.,The style icons of the Florentine brand rea... designs, striking details and prestige materials....
...he Anne Klein brand under license since 1996. The ... all-female market. The woman who chooses to wear ...ical modern woman: a successful and refined career...s and loves a sleek yet at the same time practical...
Medicine Products: